web analytics

Category Archive: Channel Mgmt: Partners – Sponsors – Sales

Aug 25 2017

MCI China Webinar – Medical Education in China: Practical Steps to Build Impact

Practical Steps to Build Impact for Medical Education in China

Thursday September 7th, 9:00- 945 am Eastern

Medical education and international exchanges is a long-standing collaboration between the US and Chinese associations. US associations are seeking to better define their impact in China beyond annual visits for scientific exchanges.

The Society of Critical Care Medicine (SCCM) has redefined their engagement strategy. In this session, SCCM CEO & Executive Vice President David J. Martin,  and Maria Tong, Director MCI China and team leader for SCCM in China, will share insights from their 5 year effort to improve SCCM engagement and partner strategy for the distribution of its training courses and publications in China.

Whether you are just considering China or are already delivering activities in this large market, you will not want to miss this 45-minute webinar to understand how SCCM sustains its long term commitment in China.  

This LIVE webinar will help you better define your impact in China, navigate the complicated stakeholder landscape, how to build recognition and buy-in, and understand the government’s objectives for the healthcare industry.

 

 

 

Bring your questions or submit in advance.

Seats are limited. For more information and to register click here

 

Aug 04 2017

MCI Education @ ASAE Toronto

If you are travelling to ASAE next week, be sure to check out the following sessions which all take place at the MTCC – South Building.

 

Build Medical Education in China: Strategy and ROI

Monday, August 14, 2017 9:00 AM – 10:00 AM

Room: 717AB

Medical education and international exchanges is a long-standing collaboration between the US and Chinese associations. US associations are seeking to better define their impact in China beyond annual visits for scientific exchanges. Society of Critical Care Medicine (SCCM) has redefined their engagement strategy. In this session, David J. Martin, CEO, SCCM will be interviewed to help us better understand the realities of structured medical education in China, the stakeholder landscape, building recognition and buy-in, and updates and implementation of NGO law.

Speakers

Florence Chua, Director Association Management and Consulting, MCI Group
David Martin, CEO/ Exec Vice Pres, Society of Critical Care Medicine

 

 

Doing Business in the Middle East – Cultural Do’s and Don’ts

 Monday, August 14, 2017    330-400pm

Global Solutions Lounge 

Learning Objectives:     

  1. Understand business culture in the UAE and the Middle East region

  2. Gain an understanding of correct etiquette and  the do’s and don’ts in a business environment

  3. How to establish a long-term business partnerships with your local partners

  4. Facts and successful business models of doing business in the region

Moderator: Ajay Bhojwani, Managing Director, MCI Middle East

Session Presenters:

  • Steen Jakobsen, Steering Committee Member, Dubai Association Centre

  • Rami Muhanna, Licensing & Relationship Management, Dubai Association Centre

 

 

 

Aug 04 2015

Chronic Diseases in China: An Opportunity for Standardized Education Programs and Enhanced Collaboration

Non-Com Disease Impact.2014

 

 

 

 

 

 

 

 

 

 

 

A recently released report “2015 Situation of Nutrition and Chronic Diseases of Chinese Residents,” indicates the incidence and mortality of chronic diseases continue to increase and have become the main causes of death in China with 79.4% of total mortality due to chronic diseases.  According to statistics, cardiovascular disease, diabetes, cancer and respiratory disease have become the top four of major threats to China’s public health.

The report stated that the relative low quality of treatment and lack of standardized clinical training in China are a contributing reason for the increased incidence and mortality rate of chronic diseases. Because of the need for long-term treatment, high incidence of complication, high rate of deformity, and high mortality, China needs advanced research, better databases, improved standardized clinical practice and medical training in order to better control the rate of incidence and mortality of chronic diseases.

The report provides a current overview on key chronic diseases:

  • Hypertension: incidence rate increased to 25.2%.
  • Diabetes: Chinese are facing an incidence rate of 9.7%. In China, about 70% diabetics do not get diagnosed, and among those who are diagnosed only 25% receive treatment.  For those receiving treatments, only 40% have conditions that are arrested and reversed.
  • Cancer and Tumor: incidence of cancer is up to 235 out of 100,000 people. Lung and breast cancer are the leading cancer types. The mortality of cancer is 144.3 out of 100,000 people with the top five cancers:  lung, liver, stomach, esophagus, and colorectal.
  • Chronic Respiratory Disease: include COPD, Asthma, Pulmonary hypertension and Sleep-disorder breathing. With the increased mortality of 68 out of 100,000 people. The incidence rate of COPD among those older than 40 years old is 9.9%.

In order to address this, China needs to keep up with advanced practice in Western medicine.  The National Health and Family Planning Committee (NHFPC) encourages enhanced cooperation and exchange of Chinese and international medicine societies in the areas of academic research, college training, and technical expertise. Herein lies many opportunities for US heath care associations to explore deeper levels of collaboration with their Chinese counterparts for the improvement of public health globally.

MCI China suggests that US medical associations with an interest in China should observe the following:

  1. Closely monitor and be sensitive to Chinese government policies and reforms because they shape and sway market development. The 12th Five-Year Plan puts healthcare reform in the spotlight, and has seen successes and challenges. The 13th Five-Plan that will be released in 2016 is expected to deepen the healthcare reform.
  2. Due to the vastly different institutional, environment and cultural factors between China and USA, it is important to invest in market insight to fully understand Chinese needs so that your association can be effective in identifying the unique selling point of your offerings.  Know that each sub-specialty will have its own unique situation and factors, therefore the maturity and/or need doesn’t equal the same for another.
  3. Understand the role of industry support and compliance requirements to build a strong stakeholder approach.

It is vital that US associations seek to collaborate with their Chinese counterparts; consider the use of local market development personnel who can help to investigate and navigate the complexities in relationships between various Chinese associations, and key opinion leaders in the same field.

Older posts «